HLAA to Hold Patient-Focused Drug Development Meeting

HLAA has received permission from the FDA to hold an Externally-Led Patient-Focused Drug Development Meeting on May 25. All are welcome to attend and participate. People with hearing loss and their experiences with daily life and technology is the focus. This meeting will be free and open to all. Your access to the YouTube Live meeting on May 25 between 10 a.m.-3 p.m. (U.S. Eastern Time) will be on this page.

HLAA held an April 8 webinar that provided an overview of our May 25 EL-PFDD meeting. The webinar PowerPoint slides and recording are online. Learn how you can participate in the May 25 meeting. Your voice is powerful.

Play webinar video recording

Meeting Registration 

Meeting registration

Patient-Focused Drug Development (PFDD) meetings were first started by the FDA to try and find a better way to hear directly from patients, their caregivers and families. The meetings explore what symptoms matter most to them, the impacts on patients’ daily lives, and patients’ experiences with currently available treatments. This information helps the FDA both during drug development as well as during review of marketing applications for new drugs

It is exciting that HLAA can lead the charge here with the FDA who will attend and listen. Our hope is that patient engagement through a PFDD will go a long way in shaping future hearing loss treatments and creating a deeper understanding of the impact of hearing loss on individuals, their quality of life and associated comorbidities. You can participate by calling in or writing comments or questions. 

Click here to Register

Questions? Email webinars@hearingloss.org.

Supporters


Acousia Therapeutics Logo

AKOUOS Logo

Decibel Therapeutics

Frequency Therapeutics Logo

Otonomy

Pipeline Therapeutics Logo

Sensorion

Partners

Thank you to these organizations and companies who support hearing health care research and solutions.